Advertisement
Novinky na Forexe
Tech Shares Expected To Boost South Korea Stock Market
The South Korea stock market on Monday halted the four-day losing streak in which it had slumped almost 35 points or 1.4 percent. The KOSPI now rests just above the 2555-point plateau and it's expected to extend its gains on Tuesday.
RTTNews |
Pred 709 dňami
New Zealand Electronic Card Sales Data Due On Tuesday
New Zealand will on Tuesday release August figures for electronic card retail sales, highlighting a light day for Asia-Pacific economic activity. In July, sales were flat on month and up 2.2 percent on year.
RTTNews
|
Pred 709 dňami
TSX Snaps 4-day Losing Streak, Ends On Firm Note
The Canadian market ended on a firm note on Monday, led by gains in technology, healthcare, materials and financials shares.
RTTNews
|
Pred 709 dňami
Dollar Loses Ground Against Major Counterparts
The U.S. dollar drifted lower against most of its major counterparts on Monday as traders looked ahead to inflation data that could influence the Federal Reserve's interest rate path.
RTTNews
|
Pred 709 dňami
Swiss Market Ends Modestly Higher
The Switzerland stock market ended modestly higher on Monday, despite suffering a mild setback around mid afternoon.
RTTNews
|
Pred 709 dňami
European Stocks Close Broadly Higher
European stocks closed broadly higher on Monday with investors evincing some buying interest at several frontline counters ahead of release of a slew of key economic data from the U.S., Europe and China.
RTTNews
|
Pred 709 dňami
Resilient Economy Lifts Dollar To Six-month High
The U.S. dollar surged again in the week ended September 8, rising to levels last seen more than six months before, amidst data that reinforced the resilience of the U.S. economy.
RTTNews
|
Pred 709 dňami
more news
Novartis Recalls One Lot Of Sandimmune Oral Solution 100 Mg/mL
Novartis AG (NVS) announced Monday it has recalled one lot of its Sandimmune Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to crystal formation observed in some bottles. The company added that no other Sandimmune formulations are impacted.
RTTNews
|
Pred 709 dňami
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews
|
Pred 709 dňami
JetBlue, Allegiant Ink Divestiture Deal In Connection With JetBlue's Combination With Spirit
JetBlue Airways Corp. (JBLU) and Allegiant (ALGT) announced Monday that the airlines have entered into a definitive agreement under which JetBlue will transfer to Allegiant all of the holdings of Spirit Airlines, Inc. (SAVE) at Boston Logan International Airport and Newark Liberty International Airport.
RTTNews
|
Pred 709 dňami
U.S. Dollar Lower Ahead Of Inflation Data
The U.S. dollar fell against its most major rivals in the European session on Monday, as investors await U.S. inflation data that could influence the Federal Reserve's interest rate path for the rest of the year.
RTTNews
|
Pred 709 dňami
Neumora Therapeutics Announces IPO Of 14.71 Mln Shares To Be Priced Between $16.00 And $18.00/Share
Biopharmaceutical company Neumora Therapeutics, Inc. revealed Monday that it will offer 14.71 million shares of its common stock in an initial public offering and expects the IPO price to be between $16.00 and $18.00 per share, according to an amended Form S-1 filing with the U.S. Securities and Exchange Commission.
RTTNews
|
Pred 709 dňami
RayzeBio Announces IPO Of 14.40 Mln Shares To Be Priced Between $16.00 And $18.00/Share
Radiopharmaceutical therapeutics company RayzeBio, Inc. revealed Monday that it will offer 14.40 million shares of its common stock in an initial public offering and expects the IPO price to be between $16.00 and $18.00 per share, according to an amended Form S-1 filing with the U.S. Securities and Exchange Commission.
RTTNews
|
Pred 709 dňami
Stay up to date!
Add Správy to your browser
Add To Chrome
